Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-apoptotic factors and causes cell death

16Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Chronic N-Methyl-d-aspartate (NMDA) administration to rats is reported to increase arachidonic acid signaling and upregulate neuroinflammatory markers in rat brain. These changes may damage brain cells. In this study, we determined if chronic NMDA administration (25 mg/kg i.p., 21 days) to rats would alter expression of pro- and anti-apoptotic factors in frontal cortex, compared with vehicle control. Results: Using real time RT-PCR and Western blotting, chronic NMDA administration was shown to decrease mRNA and protein levels of anti-apoptotic markers Bcl-2 and BDNF, and of their transcription factor phospho-CREB in the cortex. Expression of pro-apoptotic Bax, Bad, and 14-3-3ζ was increased, as well as Fluoro-Jade B (FJB) staining, a marker of neuronal loss. Conclusion: This alteration in the balance between pro- and anti-apoptotic factors by chronic NMDA receptor activation in this animal model may contribute to neuronal loss, and further suggests that the model can be used to examine multiple processes involved in excitotoxicity. © 2009 Kim et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Kim, H. W., Chang, Y. C., Chen, M., Rapoport, S. I., & Rao, J. S. (2009, September 28). Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-apoptotic factors and causes cell death. BMC Neuroscience. BioMed Central. https://doi.org/10.1186/1471-2202-10-123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free